Skip to main content

Jamie Chaft, MD

Jamie Chaft, MD
Videos
09/29/2023
At the Great Debates & Updates meeting in New York, Jamie Chaft, MD, debated in favor of using immunotherapy alone in the first-line setting for patients with high PD-L1 expression and non-small cell lung cancer.
At the Great Debates & Updates meeting in New York, Jamie Chaft, MD, debated in favor of using immunotherapy alone in the first-line setting for patients with high PD-L1 expression and non-small cell lung cancer.
At the Great Debates & Updates...
09/29/2023
Oncology
Jamie Chaft, MD
Videos
10/05/2023
At the Great Debates & Updates meeting in New York, Jamie Chaft, MD, debated in favor of neoadjuvant immunotherapy in resectable non-small cell lung cancer.
At the Great Debates & Updates meeting in New York, Jamie Chaft, MD, debated in favor of neoadjuvant immunotherapy in resectable non-small cell lung cancer.
At the Great Debates & Updates...
10/05/2023
Oncology
Jamie Chaft, MD, Memorial Sloan Kettering Cancer Center
Videos
09/17/2024
Jamie Chaft, MD, discusses the 5-year follow-up data from the IMpower010 trial which showed atezolizumab continued to provide greater improvement to disease-free survival than best supportive care for patients with resectable early-stage...
Jamie Chaft, MD, discusses the 5-year follow-up data from the IMpower010 trial which showed atezolizumab continued to provide greater improvement to disease-free survival than best supportive care for patients with resectable early-stage...
Jamie Chaft, MD, discusses the...
09/17/2024
Oncology